Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PF-00610355

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background and ObjectivesPF-00610355 is an orally inhaled long-acting β2-adrenoreceptor agonist that is being developed for the… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
AIM To assess the cardiovascular effects of a new inhaled long-acting β-adrenoceptor agonist PF-00610355 in COPD patients… Expand
Is this relevant?
2012
2012
The objective of this work was to characterize the dose–response relationship between two inhaled long-acting beta agonists (PF… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2010
Review
2010
PURPOSE OF REVIEW Because of the central role of bronchodilators in the treatment of asthma, in recent years there has been a… Expand
Is this relevant?